TrialJournal of thrombosis and thrombolysis2011

Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol.

Alexander Thomas Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.